The mean quality of life (QOL) score has been shown to be an insensitive measure of the effect of a treatment on QOL because of patient adaptation to disability. Stage, primary tumor site, surgical treatment, chemotherapy, and high attrition rates influence QOL assessment and need to be incorporated into QOL analysis.
Get full access to this article
View all access options for this article.
References
1.
1. WeymullerEAJrYuehBDeleyiannisFW, et al. Quality of life in head and neck cancer. Laryngoscope2000;110(Suppl 94):4–7.
2.
2. OozerNBBenbowJDownsC, et al. The effect of comorbidity on quality of life during radiotherapy in head and neck cancer. Otolaryngol Head Neck Surg2008;139/2:268–72.
3.
3. WeymullerEAJrYuehBDeleyiannisFW, et al. Quality of life in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg2000;126:329–35.
